• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Morgan Stanley filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    7/1/25 4:49:58 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance
    Get the next $MS alert in real time by email
    false 0000895421 0000895421 2025-07-01 2025-07-01 0000895421 MS:CommonStock0.01ParValueMember 2025-07-01 2025-07-01 0000895421 us-gaap:SeriesAPreferredStockMember 2025-07-01 2025-07-01 0000895421 us-gaap:SeriesEPreferredStockMember 2025-07-01 2025-07-01 0000895421 us-gaap:SeriesFPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesIPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesKPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesLPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesOPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesPPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:SeriesQPreferredStockMember 2025-07-01 2025-07-01 0000895421 MS:GlobalMediumtermNotesSeriesFixedRateStepupSeniorNotesDue2026Member 2025-07-01 2025-07-01 0000895421 MS:GlobalMediumtermNotesSeriesFloatingRateNotesDue2029Member 2025-07-01 2025-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

    CURRENT REPORT
    Pursuant To Section 13 or 15(d) of
    the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): July 1, 2025

     

    Morgan Stanley
    (Exact Name of Registrant
    as Specified in Charter)

     

    Delaware 1-11758 36-3145972
    (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)

     

    1585 Broadway, New York, New York   10036
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (212) 761-4000

     

    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, $0.01 par value MS New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate
    Non-Cumulative Preferred Stock, Series A, $0.01 par value
    MS/PA New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
    Non-Cumulative Preferred Stock, Series E, $0.01 par value
    MS/PE New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
    Non-Cumulative Preferred Stock, Series F, $0.01 par value
    MS/PF New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
    Non-Cumulative Preferred Stock, Series I, $0.01 par value
    MS/PI New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
    Non-Cumulative Preferred Stock, Series K, $0.01 par value
    MS/PK New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of 4.875%
    Non-Cumulative Preferred Stock, Series L, $0.01 par value
    MS/PL New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of 4.250%
    Non-Cumulative Preferred Stock, Series O, $0.01 par value
    MS/PO New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of 6.500%
    Non-Cumulative Preferred Stock, Series P, $0.01 par value
    MS/PP New York Stock Exchange
    Depositary Shares, each representing 1/1,000th interest in a share of 6.625%
    Non-Cumulative Preferred Stock, Series Q, $0.01 par value
    MS/PQ New York Stock Exchange
    Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026
    of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
    MS/26C New York Stock Exchange
    Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029
    of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
    MS/29 New York Stock Exchange

     

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

    Item 8.01 Other Events.

     

    On July 1, 2025, Morgan Stanley (the “Company”) announced it will increase its quarterly common stock dividend to $1.00 per share from the current $0.925 per share, beginning with the common stock dividend expected to be declared by the Company’s Board of Directors (the “Board”) in the quarter ending September 30, 2025 (the “third quarter”). In addition, the Board reauthorized a multi-year common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter. The share repurchases will be exercised from time to time at prices the Company deems appropriate, subject to various considerations, including current market conditions, the Company’s capital position and future economic and earnings outlook.

     

    On June 27, 2025, the Board of Governors of the Federal Reserve System published summary results of its 2025 supervisory stress tests, as a result of which the Company expects, under current regulatory standards, to be subject to a Stress Capital Buffer (“SCB”) of 5.1% from October 1, 2025 to September 30, 2026.

     

    The Board of Governors of the Federal Reserve System has issued a proposed rulemaking that, if adopted, would change the standards by which large bank holding companies’ SCBs are calculated. If relevant, the Company will provide updated information on applicable regulatory capital standards in response to a final rulemaking, including any change in the Company’s SCB.

     

    A copy of the press release relating to this announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K (including the Exhibit hereto) contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made, which reflect management’s current estimates, projections, expectations, assumptions, interpretations or beliefs of the Company’s future results, regulatory capital levels and future capital actions, including common stock dividends and common equity share repurchases, and which are subject to risks and uncertainties that may cause actual results to differ materially. The Company does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of forward-looking statements. For a discussion of additional risks and uncertainties that may affect the future results, regulatory capital levels and future capital actions of the Company, please see “Forward-Looking Statements” preceding Part I, Item 1, “Competition” and “Supervision and Regulation” in Part I, Item 1, “Risk Factors” in Part I, Item 1A, “Legal Proceedings” in Part I, Item 3, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 and “Quantitative and Qualitative Disclosures about Risk” in Part II, Item 7A, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and other items throughout the Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments thereto.

     

    Item 9.01. Financial Statements and Exhibits.
        (d) Exhibits
    Exhibit
    Number
    Description
    99.1 Press Release of the Company, dated July 1, 2025.
    101 Interactive Data Files pursuant to Rule 406 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBL”).
    104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

     

     

    MORGAN STANLEY

    (Registrant)

       
    Date: July 1, 2025 By: /s/ Martin M. Cohen
        Name: Martin M. Cohen
        Title: Corporate Secretary

     

     

    Get the next $MS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MS

    DatePrice TargetRatingAnalyst
    11/26/2024Buy → Hold
    HSBC Securities
    11/15/2024$142.00Underweight → Equal Weight
    Wells Fargo
    10/4/2024$118.00Hold → Buy
    HSBC Securities
    9/11/2024Buy → Neutral
    Goldman
    8/2/2024$99.00 → $95.00Equal Weight → Underweight
    Wells Fargo
    7/17/2024Outperform → Perform
    Oppenheimer
    1/17/2024$94.00 → $87.00Overweight → Neutral
    JP Morgan
    1/17/2024$102.00 → $91.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $MS
    SEC Filings

    See more
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 4:53:42 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form FWP filed by Morgan Stanley

      FWP - MORGAN STANLEY (0000895421) (Subject)

      7/1/25 4:52:06 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance
    • Morgan Stanley filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - MORGAN STANLEY (0000895421) (Filer)

      7/1/25 4:49:58 PM ET
      $MS
      Investment Bankers/Brokers/Service
      Finance